Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2025-02-05 2025-02-04
Drug Identification Number 02536315 02536315
Brand name TESTOSTERONE ENANTHATE INJECTION, USP TESTOSTERONE ENANTHATE INJECTION, USP
Common or Proper name TESTOSTERONE ENANTHATE INJECTION, USP TESTOSTERONE ENANTHATE INJECTION, USP
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients TESTOSTERONE ENANTHATE TESTOSTERONE ENANTHATE
Strength(s) 200MG 200MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5mL 5mL
ATC code G03BA G03BA
ATC description ANDROGENS ANDROGENS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2025-02-04 2025-02-04
Actual start date
Estimated end date 2025-03-01 2025-03-01
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Inventory available at distributors. Inventory available at distributors.
Health Canada comments